Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322:1617–21.VichinskyEPEarlesAJohnsonRA,Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.1990;322:1617–21.10.1056/NEJM1990060732223012342522Search in Google Scholar
Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease: the Cooperative Study of Sickle Cell Disease. Blood 1990;76:1431–7.RosseWFGallagherDKinneyTR,Transfusion and alloimmunization in sickle cell disease: the Cooperative Study of Sickle Cell Disease.1990;76:1431–7.10.1182/blood.V76.7.1431.1431Search in Google Scholar
Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002;42:37–43.AygunBPadmanabhanSPaleyCChandrasekaranV.Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.2002;42:37–43.10.1046/j.1537-2995.2002.00007.x11896310Search in Google Scholar
Castro O, Sandler SG, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002;42:684–90.CastroOSandlerSGHouston-YuPRanaS.Predicting the effect of transfusing only phenotype matched RBCs to patients with sickle cell disease: theoretical and practical implications.2002;42:684–90.10.1046/j.1537-2995.2002.00126.x12147019Search in Google Scholar
Sakhalkar VS, Roberts K, Hawthorne LM, et al. Allosensitization in patients receiving multiple blood transfusions. Ann N Y Acad Sci 2005;1054:495–9.SakhalkarVSRobertsKHawthorneLM,Allosensitization in patients receiving multiple blood transfusions.2005;1054:495–9.10.1196/annals.1345.07216339705Search in Google Scholar
Lasalle-Williams M, Nuss R, Le T, et al. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME). Transfusion 2011;51:1732–9.Lasalle-WilliamsMNussRLeT,Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME).2011;51:1732–9.10.1111/j.1537-2995.2010.03045.x21332724Search in Google Scholar
Miller ST, Kim HY, Weiner DL, et al. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Transfusion 2013;53:704–9.MillerSTKimHYWeinerDL,Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.2013;53:704–9.10.1111/j.1537-2995.2012.03796.x509639122804353Search in Google Scholar
Telen MJ, Afenyi-Annan A, Garrett ME, et al. Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival. Transfusion 2015;55:1378–87.TelenMJAfenyi-AnnanAGarrettME,Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival.2015;55:1378–87.10.1111/trf.12940445145025444611Search in Google Scholar
Vichinsky EP, Luban NL, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086–92.VichinskyEPLubanNLWrightE,Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial.2001;41:1086–92.10.1046/j.1537-2995.2001.41091086.x11552063Search in Google Scholar
Tahhan HR, Holbrook CT, Braddy LR, et al. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 1994;34:562–69.TahhanHRHolbrookCTBraddyLR,Antigen-matched donor blood in the transfusion management of patients with sickle cell disease.1994;34:562–69.10.1046/j.1537-2995.1994.34794330008.x8053036Search in Google Scholar
Cox JV, Steane E, Cunningham G, Frenkel EP. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med 1988;148:2485–9.CoxJVSteaneECunninghamGFrenkelEP.Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.1988;148:2485–9.10.1001/archinte.1988.00380110115024Search in Google Scholar
Talano JA, Hillery CA, Gottschall JL, et al. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics 2003;111:e661–5.TalanoJAHilleryCAGottschallJL,Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.2003;111:e661–5.10.1542/peds.111.6.e66112777582Search in Google Scholar
Vidler JB, Gardner K, Amenyah K, et al. Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience. Br J Haematol 2015;169:746–53.VidlerJBGardnerKAmenyahK,Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience.2015;169:746–53.10.1111/bjh.1333925753472Search in Google Scholar
Nickle RS, Hendrickson JE, Fasano RM, et al. Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series. Transfusion 2016;56:107–14.NickleRSHendricksonJEFasanoRM,Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series.2016;56:107–14.10.1111/trf.1337926509333Search in Google Scholar
Chou ST, Jackson T, Vege S, et al. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 2013;122:1062–71.ChouSTJacksonTVegeS,High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.2013;122:1062–71.10.1182/blood-2013-03-49062323723452Search in Google Scholar
Casas J, Friedman DF, Jackson T, et al. Changing practice: red blood cell typing by molecular methods for patients with sickle cell disease. Transfusion 2015;55:1388–93.CasasJFriedmanDFJacksonT,Changing practice: red blood cell typing by molecular methods for patients with sickle cell disease.2015;55:1388–93.10.1111/trf.12987900387625573464Search in Google Scholar
Anstee D. Red cell genotyping and the future of pretransfusion testing. Blood 2009;114:248–56.AnsteeD.Red cell genotyping and the future of pretransfusion testing.2009;114:248–56.10.1182/blood-2008-11-14686019411635Search in Google Scholar
Sapatnekar S, Figueroa PI. How do we use molecular red blood cell antigen typing to supplement pretransfusion testing? Transfusion 2014;54:1452–8.SapatnekarSFigueroaPI.How do we use molecular red blood cell antigen typing to supplement pretransfusion testing?2014;54:1452–8.10.1111/trf.1262324654601Search in Google Scholar
Meyer S, Vollmert C, Trost N, et al. High-throughput Kell, Kidd, and Duffy matrix-assisted laser desorption/ionization, time-of-flight mass spectrometry–based blood group genotyping of 4000 donors shows close to full concordance with serotyping and detects new alleles. Transfusion 2014;54:3198–207.MeyerSVollmertCTrostN,High-throughput Kell, Kidd, and Duffy matrix-assisted laser desorption/ionization, time-of-flight mass spectrometry–based blood group genotyping of 4000 donors shows close to full concordance with serotyping and detects new alleles.2014;54:3198–207.10.1111/trf.1271524845979Search in Google Scholar
Kappler-Gratias S, Peyrard T, Beolet M, et al. Blood group genotyping by high-throughput DNA analysis applied to 356 reagent red blood cell samples. Transfusion 2011;51:36–42.Kappler-GratiasSPeyrardTBeoletM,Blood group genotyping by high-throughput DNA analysis applied to 356 reagent red blood cell samples.2011;51:36–42.10.1111/j.1537-2995.2010.02802.x20707859Search in Google Scholar
Montpetit A, Phillips MS, Mongrain I, et al. High-throughput molecular profiling of blood donors for minor red blood cell and platelet antigens. Transfusion 2006;46:841–8.MontpetitAPhillipsMSMongrainI,High-throughput molecular profiling of blood donors for minor red blood cell and platelet antigens.2006;46:841–8.10.1111/j.1537-2995.2006.00805.x16686853Search in Google Scholar
International Society of Blood Transfusion (ISBT). http://www.isbtweb.org/fileadmin/user_upload/ISBT004-RHCE15th_July_2019.pdf. Accessed July 2020.http://www.isbtweb.org/fileadmin/user_upload/ISBT004-RHCE15th_July_2019.pdf. Accessed July 2020.Search in Google Scholar
Reid M, Lomas-Francis C, Olsson ML. The blood group antigens factsbook. 3rd ed. London: Academic Press, 2012.ReidMLomas-FrancisCOlssonML..3rd ed.London:Academic Press,2012.10.1016/B978-0-12-415849-8.00026-0Search in Google Scholar
Wilkinson K, Harris S, Gaur P, et al. Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell disease. Transfusion 2012;52:381–8.WilkinsonKHarrisSGaurP,Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell disease.2012;52:381–8.10.1111/j.1537-2995.2011.03288.x21827505Search in Google Scholar
López M, Apraiz I, Rubia M, et al. Performance evaluation study of ID CORE XT, a high throughput blood group genotyping platform. Blood Transfus 2018;16:193–9.LópezMApraizIRubiaM,Performance evaluation study of ID CORE XT, a high throughput blood group genotyping platform.2018;16:193–9.Search in Google Scholar